TamaFlex

Precautions re: Children

Keep out of reach of children.

Storage

Store in a cool, dry place.

General Statements: All Other Content

For more information: 1-888-462-2548 TamaFlex.com

Brand IP Statement(s) re: (c), (TM), (SM)

TamaFlex is a trademark of NXTS USA, Inc. Patents pending. ApresFlex is a registered trademark of Laila Nutraceuticals exclusively licensed to PL Thomas Laila Nutraceuticals LLC. U.S. Patent #8,551,496 and other patents pending.

Formulation re: Other

Fast Acting Proven joint support Feel the difference in just 5 days 7x more comfort & 7.5x better function in 30 days In a randomized, double-blinded trial, 90 healthy adults took 125 mg of TamaFlex or placebo twice daily for 90 days. Those taking TamaFlex had improved (i) joint comfort, stiffness and function (WOMAC), (ii) walking speed and distance and (iii) use of stairs. Improvements were seen as early as 2 weeks for comfort and stiffness. In randomized, double-blind study, 67 adults took 50 mg of ApresFlex or a placebo twice daily. Those taking ApresFlex had improvements in joint stiffness, comfort and function (WOMAC) that were 5, 7 and 43 times greater vs. the placebo group after 30 days. Improvements were seen as early as 5 days.

General Statements: All Other Content

60-Day supply

FDA Statement of Identity

Dietary Supplement

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Suggested/Recommended/Usage/Directions

Directions: As a dietary supplement, take one capsule in the morning and one in the evening.

Precautions re: Allergies

Contains a bioengineered food ingredient.

Precautions re: Pregnant or Nursing or Prescription Medications

Warning: Consult your physician prior to using this product if you are pregnant, nursing, taking medication or have a medical condition.

Precautions re: All Other

Discontinue use two weeks prior to surgery.